RegeneRx Biopharma gets Australian patent
The company said that the new patent will expire in 2023. RegeneRx claims that it holds patents and patent applications worldwide related to its products and holds an
Remepy has closed a $36m Series A financing round to accelerate its pharmaceutical co-development partnerships and expand its hybrid drug pipeline.
Lubrizol is a US based specialty chemical company that produces ingredients and additives for pharmaceuticals and specialty materials. Lubrizol Advanced Materials focuses on branded specialty polymers and additives